Primary |
Nausea |
18.1% |
Prophylaxis Of Nausea And Vomiting |
18.1% |
Drug Use For Unknown Indication |
17.1% |
Product Used For Unknown Indication |
11.3% |
Vomiting |
7.2% |
Premedication |
4.8% |
Chemotherapy |
4.1% |
Hyperemesis Gravidarum |
2.8% |
Prophylaxis |
2.5% |
Breast Cancer |
2.4% |
Hypertension |
1.8% |
Depression |
1.5% |
Pain |
1.5% |
Drug Exposure During Pregnancy |
1.4% |
Non-small Cell Lung Cancer |
1.4% |
Colon Cancer |
1.0% |
Acute Myeloid Leukaemia |
0.9% |
Neoplasm Malignant |
0.7% |
Antiemetic Supportive Care |
0.7% |
Bronchitis |
0.6% |
|
Vomiting |
18.5% |
Death |
15.5% |
Drug Ineffective |
14.0% |
Nausea |
7.9% |
Drug Exposure During Pregnancy |
7.0% |
Urticaria |
3.4% |
Neoplasm Malignant |
3.0% |
Constipation |
2.6% |
Rash Papular |
2.6% |
Weight Decreased |
2.6% |
Disease Progression |
2.5% |
Headache |
2.5% |
Off Label Use |
2.5% |
Tremor |
2.5% |
Live Birth |
2.3% |
Malaise |
2.3% |
Pharmaceutical Product Complaint |
2.3% |
Therapeutic Response Unexpected |
2.3% |
Dizziness |
1.9% |
Extrapyramidal Disorder |
1.9% |
|
Secondary |
Product Used For Unknown Indication |
28.1% |
Nausea |
13.3% |
Drug Use For Unknown Indication |
7.8% |
Foetal Exposure During Pregnancy |
6.5% |
Premedication |
6.0% |
Breast Cancer |
5.9% |
Vomiting |
5.7% |
Prophylaxis |
3.7% |
Pain |
3.3% |
Prophylaxis Of Nausea And Vomiting |
2.6% |
Depression |
2.2% |
Acute Myeloid Leukaemia |
2.1% |
Lymphoma |
2.0% |
Chemotherapy |
2.0% |
Hypertension |
1.8% |
Chronic Lymphocytic Leukaemia |
1.6% |
Constipation |
1.6% |
Migraine |
1.4% |
Chronic Obstructive Pulmonary Disease |
1.3% |
Non-small Cell Lung Cancer |
1.3% |
|
Vomiting |
19.1% |
Nausea |
8.2% |
Death |
6.0% |
Premature Baby |
6.0% |
Shock |
6.0% |
Weight Decreased |
6.0% |
Drug Hypersensitivity |
5.6% |
White Blood Cell Count Decreased |
5.6% |
Chills |
4.5% |
Tremor |
4.1% |
Malaise |
3.4% |
Respiratory Distress |
3.4% |
Vertigo |
3.4% |
Dehydration |
3.0% |
Pruritus |
3.0% |
Chest Pain |
2.6% |
Intra-uterine Death |
2.6% |
Photosensitivity Reaction |
2.6% |
Somnolence |
2.6% |
Drug Ineffective |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
28.6% |
Drug Use For Unknown Indication |
17.7% |
Nausea |
8.9% |
Pain |
7.3% |
Prophylaxis |
3.6% |
Hypertension |
3.2% |
Non-small Cell Lung Cancer |
3.0% |
Breast Cancer |
3.0% |
Premedication |
2.9% |
Multiple Myeloma |
2.8% |
Vomiting |
2.7% |
Constipation |
2.3% |
Depression |
2.3% |
Gastrooesophageal Reflux Disease |
2.3% |
Anxiety |
2.1% |
Crohn's Disease |
1.8% |
Abdominal Pain |
1.6% |
Insomnia |
1.6% |
Breast Cancer Metastatic |
1.2% |
Asthma |
1.1% |
|
Vomiting |
23.8% |
Weight Decreased |
8.5% |
White Blood Cell Count Decreased |
6.0% |
Pulmonary Embolism |
5.6% |
Pyrexia |
5.1% |
Thrombocytopenia |
5.1% |
Nausea |
5.1% |
Death |
4.8% |
Pneumonia |
3.9% |
Pain |
3.8% |
Urinary Tract Infection |
3.4% |
Suicide Attempt |
3.3% |
Sepsis |
3.0% |
Renal Failure |
3.0% |
Renal Failure Acute |
3.0% |
Weight Increased |
2.8% |
Neutropenia |
2.6% |
Rash |
2.5% |
Dehydration |
2.4% |
Diarrhoea |
2.3% |
|
Interacting |
Lymphoma |
26.3% |
Smoking Cessation Therapy |
10.5% |
Cancer Pain |
7.9% |
Product Used For Unknown Indication |
7.9% |
Chronic Lymphocytic Leukaemia |
5.3% |
Epilepsy |
5.3% |
Acute Lymphocytic Leukaemia |
2.6% |
Anaemia |
2.6% |
Anxiety |
2.6% |
Bacterial Infection |
2.6% |
Bladder Transitional Cell Carcinoma |
2.6% |
Chemotherapy |
2.6% |
Constipation |
2.6% |
Decreased Appetite |
2.6% |
Haemoptysis |
2.6% |
Hypertension |
2.6% |
Pneumonia |
2.6% |
Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
Respiratory Failure |
2.6% |
Tachycardia |
2.6% |
|
Drug Level Decreased |
16.7% |
Nausea |
16.7% |
Electrocardiogram Qt Prolonged |
8.3% |
Hallucination |
8.3% |
Ileus |
8.3% |
Nightmare |
8.3% |
Postoperative Fever |
8.3% |
Tachycardia |
8.3% |
Tumour Lysis Syndrome |
8.3% |
Vision Blurred |
8.3% |
|